Stroke Rates and Clinical Outcomes After Transcaval Transcatheter Aortic Valve Replacement With and Without Central Embolic Protection: A Single-Center Experience.

Notably, CEP was associated with a small, near-significant reduction in stroke associated with death or discharge to nonhome location but was not associated with risk reduction in nondisabling stroke. 16 , 17 Similarly, the PROTECTED TAVR trial reported rates of 2.3% with CEP compared with 2.9% without CEP, also in an all-femoral cohort. 5 More recently, t

also in 2,306 other papers